CSI Market
Sign In | Register

Clover Health Investments (CLOV) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CLOV quarterly Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Clover Health Investments's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-85.55
Depreciation & amortization-0.16
Amortization of Other Assets0.00
Increase (Decrease) in Reinsurance Recoverable0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation103.66
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Amortization Of Notes And Securities Discounts-
Increase Decrease In Fair Value Adjustment Of Warrants0.02
Amortization Expenses Of Warrants-
Increase Decrease In Operating Lease Right Of Use Assets-
Increase Decrease In Unpaid Claims-3.15
Increase Decrease In Premium Deficiency Reserve-
Increase Decrease In Performance Year Obligation-
Debt Securities Available For Sale Realized Gain Loss-
Realized Investment Losses Gains-0.98
Premium Deficiency Testing Expense Benefit Long Duration Contract Amount-
Increase Decrease In Non Insurance Payable-
Marketable Securities Unrealized Gain Loss-
Increase Decrease In Contract With Customer Liability-
Premium Deficiency Testing Benefit Long Duration Contract Amount-
Increase Decrease In Cash Flows From Discontinued Operations-
Income taxes0.00
Gain (Loss) on Investments0.00
Accounts Receivable-43.06
Increase (Decrease) in Accounts Payable and Accrued Liabilities1.65
Increase (Decrease) in Accrued Salaries-3.05
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense-5.04
Other Working Capital-31.28
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-66.93
Investing Activities
Capital Expenditures-2.04
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Payments to Acquire Available-for-sale Securities0.00
Real Estate Investments0.00
Proceeds From Sale Of Short Term Investments And Available For Sale Securities185.16
Proceeds From Maturity Of Short Term Investments And Debt Securities Available For Sale-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-205.10
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net26.05
Discontinued operations0.00
Net Cash Flow from Investing Activities4.08
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-17.20
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-194.54
Proceeds From Sale Of Units Net Of Underwriting Discounts Paid-
Proceeds From Investors In Connection With Business Combination-
Repayment Of Investors Funds In Connection With Business Combination-
Proceeds From Reverse Capitalization Net Of Transaction Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents194.54
Proceeds From Issuance Of Common Stock Net Of Early Exercise Liability0.72
Cash Paid For Shares Withheld Related To Stock Based Compensation-36.90
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-53.38
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-68.98
Total Cash Flow-116.24
4 historic quarters locked

Sign in to unlock the full Clover Health Investments cash flow history.

Sign In Create Free Account

About Clover Health Investments Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 27, 2026
  • Source: clov-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001801170-26-000057

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License